Myovant Sciences Ltd.
USD26.98
-0.01 (-0.04%)
CEO
David C. Marek
IPO Date
2016-10-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
GB
Open
$26.99
Prev. Close
$26.99
Day Low
$26.98
Day High
$27.00
52W Low
$7.67
52W High
$27.06
Market Cap
$2.62B
Volume
2.26M
| -7.3 |
| 31 Mar 2020 | FY | 0.0% | 0.0% | 266.9% | -272.8% | -1.17 | 1.02 | -2.2 |
| 31 Mar 2019 | FY | 0.0% | 0.0% | -6311.7% | -158.1% | 22.93 | 2.32 | -5.8 |
| 31 Mar 2018 | FY | 0.0% | 0.0% | -379.7% | -120.3% | 1.16 | 3.09 | -8.8 |
| 31 Mar 2017 | FY | 0.0% | 0.0% | -50.0% | -45.0% | 0.00 | 10.04 | -6.9 |
| 31 Mar 2016 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.00 | 0.0 |
| -9.5 |
| 30 Jun 2022 | Q1 | 80.3% | -18.2% | 4.4% | -4.6% | -0.76 | 1.89 | -14.0 |
| 31 Mar 2022 | Q4 | 69.2% | -103.0% | 12.5% | -11.4% | -0.78 | 1.95 | -5.3 |
| 31 Dec 2021 | Q3 | 70.0% | -116.5% | 14.7% | -10.5% | -0.85 | 2.14 | -5.7 |
| 30 Sept 2021 | Q2 | 85.6% | -27.7% | 5.6% | -3.2% | -0.96 | 2.44 | -24.0 |
| 30 Jun 2021 | Q1 | 84.7% | -150.2% | 15.4% | -8.5% | -0.92 | 2.28 | -8.5 |
| 31 Mar 2021 | Q4 | 92.0% | -330.7% | 23.0% | -11.2% | -1.04 | 2.50 | -5.8 |
| 31 Dec 2020 | Q3 | 100.0% | -5355.3% | 27.3% | -9.5% | -1.20 | 2.99 | -8.4 |
| 30 Sept 2020 | Q2 | 0.0% | 0.0% | 33.6% | -49.4% | -1.33 | 1.75 | -4.7 |